I pay tribute to the noble Lord and his doughty campaigning on this subject over many years, not just in this House but as a constituency MP in the House of Commons. This policy is being taken forward as a UK-wide measure, which has required co-ordination across the four nations, including respecting their different election cycles. Following notification to the EU Commission, in respect to Northern Ireland, and the World Trade Organization, in accordance with international obligations, in England we plan to lay legislation in July. Noble Lords will wish to be reassured that effecting this policy decision remains a government priority and will not be subject to any further delay.
My Lords, 19 years ago I led a Westminster Hall debate on the fortification of basic foodstuffs with folic acid. I was supported subsequently by the noble Lord, Lord Rooker, in his capacity as chairman of the Food Standards Agency. Hydrocephalus and spina bifida still affect many families, and the cumulative impact of expenditure to treat those conditions is huge on the public purse, as well as the trauma and tragedy involved for parents. I reiterate the points raised and welcome this Government’s imperative to get this done and fall into line with thousands of other politicians, and Governments across the world, who have taken this step.
My noble friend raises an important point and he is absolutely right. The sooner we get on with the implementation of folic acid, the better.
I am aware that the data is made available to the research community. However, as I said in a previous answer, it is reliant on good-quality data and working with the research community. If the noble Lord knows of any specific examples, I am very happy to take that away and look into it specifically.
My Lords, recent industrial action has caused great worry and distress for many cancer patients and their families. I press my noble friend the Minister specifically on what efforts he and the department are taking to alleviate the impact of the strikes and refocus the energy on reducing cancer treatment waiting times affected by the industrial action.
My noble friend raises a very important point. Despite a very challenging environment, where ongoing industrial action has been planned, the number of patients waiting more than 78 weeks for care has decreased from 124,000 in September 2021 to just under 11,500 at the end of April 2023. There has been significant progress in reducing the cancer backlog, which was down by 4,500 patients at the end of April 2023 compared with the same period last year.
The level of disruption has, none the less, been significant. The main impact has been on cancer surgery, in addition to some out-patient appointments. The recent nursing and junior doctor strikes came after previous industrial action, meaning that the accumulative impact will continue for some time. The department and NHS England are monitoring the impact and, where possible, taking action to mitigate the impact on patients.